Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Patients with depression, anxiety more likely to experience heart attack, stroke

Middle-aged men and women with psychological conditions such as anxiety and depression are likely at an increased risk for cardiovascular complications, according to research out of Australia.

Thumbnail

Staff shortage prompts suspension of Oregon’s lone heart transplant center

Oregon’s only heart transplant program has suspended operations for at least two weeks after three cardiologists either left or announced plans to leave Oregon Health & Science University, The Oregonian reported Aug. 27.

Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

Thumbnail

Systolic BP below 110 doubles risk of fainting, serious falls

Among 477,516 people in the Kaiser Permanente Southern California health system who were treated for high blood pressure, those who reached systolic blood pressure below 110 mm Hg at any point during a one-year period were twice as likely to faint or fall as patients who remained above that threshold.

Daily aspirin unlikely to prevent 1st heart attack

Though it’s used routinely to discourage repeat cardiovascular disease (CVD) events, a daily dose of aspirin is unlikely to prevent a first-time heart attack, according to research presented this week in Munich.

Rivaroxaban fails to prevent VTE after hospital discharge

For patients hospitalized with an acute illness, prescribing rivaroxaban for 45 days after discharge doesn’t significantly reduce the risk of venous thromboembolism (VTE) or VTE-related death, according to research presented at the European Society of Cardiology Congress and published online in the New England Journal of Medicine.

1-year outcomes still support culprit-only PCI for cardiogenic shock

For patients with acute myocardial infarction (MI) complicated by cardiogenic shock, stenting only the culprit lesion showed a trend toward improved one-year survival when compared to multivessel PCI, according to the latest results of the CULPRIT-SHOCK trial presented at the European Society of Cardiology Congress in Munich.

Thumbnail

40% of AFib patients have ‘silent’ brain damage that could explain predisposition to dementia

More than 40 percent of patients with atrial fibrillation (AFib) but no record of stroke or transient ischemic attack have previously unknown, “silent” brain damage, according to research presented this week at the European Society of Cardiology Congress (ESC) in Munich. The findings might explain why those with AFib also face an increased risk of cognitive dysfunction and dementia.

Displaying 4433 - 4440 of 10775

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.